BioSpace News Archive

Pharm Country

Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference

Anavex Life Sciences Corp. announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the H.C. Wainwright Virtual BioConnect 2022 Conference being held January 10-13, 2022.

January 5, 2022
·
3 min read
BioForest

Athira Pharma Provides 2022 Pipeline Outlook

Topline data from ACT-AD Phase 2 Alzheimer’s disease study in 2Q22 LIFT-AD Phase 3 Alzheimer’s disease study sample size increased to strengthen statistical power of co-key secondary endpoints and enhance the potential for a single pivotal clinical study.

January 5, 2022
·
7 min read
BioMidwest

Ocuphire Provides Corporate Update: Announcing Enrollment Completion of Phase 3 Nyxol Trial, Enrollment Initiation of Nyxol Pediatric Trial, and an Investor R&D Day in January

Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today provided a corporate update available on the Company’s website.

January 5, 2022
·
8 min read
Business

Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

Akoya Biosciences, Inc., and Bio-Techne today announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.

January 5, 2022
·
5 min read
Autolus Therapeutics to Present at Conferences During January 2022

Autolus Therapeutics plc today announced that they are scheduled to deliver a corporate presentation at the following virtual conferences: Dr. Christian Itin, Chief Executive Officer, will present at the 40th annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 8.15 am ET.

January 5, 2022
·
1 min read
Biotech Beach

SAB Biotherapeutics to Present at 2022 H.C. Wainwright BioConnect Virtual Conference

SAB Biotherapeutics announced that Eddie J. Sullivan, PhD, co-founder, president, and CEO, will present at the H.C. Wainwright BioConnect Virtual Conference occurring January 10-13, 2022.

January 5, 2022
·
1 min read
BioMidwest

Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

Bio-Techne and Akoya Biosciences, Inc. announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.

January 5, 2022
·
5 min read
BioMidwest

FluGen to Present at the 40th Annual J.P. Morgan Healthcare Conference

FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced Boyd Clarke, Executive Chairman is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference.

January 5, 2022
·
1 min read
Biotech Beach

NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company’s Thoracolumbar Interbody Portfolio

NuVasive, Inc. (NASDAQ: NUVA), today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax® Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery.

January 5, 2022
·
5 min read
Genetown

Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

Leap Therapeutics, Inc. announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect 2022 Conference, being held virtually on January 10-13, 2022.

January 5, 2022
·
3 min read